Search

Embecta Corp

Aperta

SettoreSettore sanitario

6.17 -0.64

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

5.9

Massimo

6.23

Metriche Chiave

By Trading Economics

Entrata

25M

21M

Vendite

50M

272M

P/E

Media del settore

4.065

48.735

EPS

0.56

Rendimento da dividendi

7.68

Margine di Profitto

7.766

Dipendenti

1,850

EBITDA

20M

65M

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

7.68%

2.24%

Utili prossimi

24 nov 2026

Prossima data del Dividendo

17 dic 2026

Prossima data del' Ex Dividendo

4 dic 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

118M

339M

Apertura precedente

6.81

Chiusura precedente

6.17

Embecta Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

13 ott 2026, 20:13 UTC

Embecta Corp's shares declined during after-market hours on Tuesday, maintaining a loss since the regular session close.

12 ott 2026, 23:06 UTC

Embecta Corp's shares advanced modestly higher in after-market trading, recovering from a low point earlier in the session while remaining above its 20-day moving average.

9 ott 2026, 19:35 UTC

Embecta Corp's shares are roughly flat, showing little change since Thursday's close, while positioned above its 20-day moving average.

8 ott 2026, 20:07 UTC

News

Embecta Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC, regarding potential corporate wrongdoing involving its officers and directors.

7 ott 2026, 20:08 UTC

Embecta Corp shares fell modestly, retracing from a peak earlier in the day, but remain above their 20-day moving average.

6 ott 2026, 19:20 UTC

Embecta Corp is trading higher, supported by broader market gains and positive economic indicators, despite earlier pulling back from a session high.

5 ott 2026, 22:31 UTC

Embecta Corp is experiencing downward pressure in after-market trading, with losses accelerating since Monday's close while remaining above its 20-day moving average.

2 ott 2026, 23:20 UTC

Embecta Corp is seeing a notable decline in after-market trading, reaching its lowest cumulative return since Friday's close.

1 ott 2026, 20:07 UTC

Embecta Corp is advancing, remaining well above its previous close and significantly above its 20-day moving average, despite a slight pullback earlier in the session.

30 set 2026, 20:02 UTC

Embecta Corp shares fell sharply after an early high, continuing a decline since Tuesday's close while remaining above the 20-day moving average.

29 set 2026, 20:07 UTC

News

Embecta Corp shares are declining as Bronstein, Gewirtz & Grossman, LLC announced an investigation into potential corporate wrongdoing by the company's officers and directors.

28 set 2026, 20:12 UTC

Embecta Corp is trading lower in after-market hours, continuing a decline since Monday, though it remains above its 20-day moving average.

25 set 2026, 20:01 UTC

Embecta Corp is sharply higher, reaching a notable high and trading above its 20-day moving average, continuing an upward trend since Thursday's close.

24 set 2026, 20:07 UTC

Embecta Corp's shares advanced modestly, remaining above the 20-day moving average and near the upper end of their one-month trading range.

22 set 2026, 20:02 UTC

Embecta Corp is trading sharply higher, reaching a peak earlier in the session and remaining above its 20-day moving average.

21 set 2026, 21:21 UTC

Embecta Corp is declining in after-market trading, reflecting a significant dip since Monday's close and currently positioned in the middle of its one-month trading range.

18 set 2026, 20:04 UTC

Embecta Corp is trading higher, continuing its rise from Thursday and maintaining momentum above its 20-day moving average with three consecutive higher daily finishes.

16 set 2026, 20:10 UTC

Embecta Corp is advancing amid a positive market environment, though it remains below its 20-day moving average and near the lower end of its one-month range.

15 set 2026, 20:07 UTC

News

Embecta Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC, contributing to a decline in shares amid broader market pressures.

14 set 2026, 20:04 UTC

Embecta Corp shares are higher today, rebounding from an early dip without specific news to explain the movement. Broader market concerns include rising crude oil prices.

11 set 2026, 19:16 UTC

Embecta Corp shares are higher amid U.S. Consumer Price Index data, which showed inflation at 3.4% annually, aligning with forecasts.

10 set 2026, 21:31 UTC

Embecta Corp shares are higher in after-market trading, continuing an upward move since Thursday's close, despite being below its 20-day moving average.

9 set 2026, 20:02 UTC

Embecta Corp shares are lower today, continuing a decline since Tuesday's close. The stock peaked earlier in the session before reversing sharply.

8 set 2026, 20:02 UTC

News

Embecta Corp shares are lower as an investigation raises governance concerns among shareholders. Investors are assessing potential implications of the inquiry.

3 set 2026, 19:36 UTC

Embecta Corp shares are higher as market sentiment improves amid easing interest rate concerns and declining Treasury yields.

2 set 2026, 23:36 UTC

Embecta Corp. shares are higher in after-market hours, reflecting broader market trends amid ADP's report of weak private sector job growth in August.

1 set 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, with no specific news identified to explain the decline amid broader market concerns over rising crude oil prices.

31 ago 2026, 20:07 UTC

Embecta Corp shares are higher today, trading near the upper end of their one-month range and above the 20-day moving average.

28 ago 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, with no specific news identified. The stock has shown strong performance over the past month.

27 ago 2026, 20:07 UTC

Event
News

Bronstein, Gewirtz & Grossman, LLC is investigating Embecta Corp for potential corporate wrongdoing. Shares are trading roughly flat following the company's recent $0.01 dividend.

Confronto tra pari

Modifica del prezzo

Embecta Corp Previsione

Consenso sulla valutazione

By TipRanks

Vendi

2 ratings

0

Acquista

1

Mantieni

1

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
help-icon Live chat